About Ayesha BioMed
Science that helps you understand your biology.
Ayesha BioMed is the biomedical research, education, and preventive health platform of Zarah B.V., dedicated to translating advances in systems biology, molecular science, and translational research into practical biomedical guidance for individuals seeking to improve their long-term health.
Founded by Nisar Ahmed Khan, PhD (cum laude), Ayesha BioMed represents more than twenty-five years of scientific research spanning molecular immunology, peptide therapeutics, systems biology, computational biology, and translational medicine.
Rather than focusing on isolated symptoms, Ayesha BioMed seeks to understand how biological systems interact over time—helping individuals make informed, evidence-based decisions that support healthier ageing and disease prevention.
The platform combines scientific interpretation with thoughtful, personalised guidance while respecting the essential role of licensed medical care.
Our Philosophy
Healthcare has never generated more data.
Laboratory tests, wearable devices, imaging, genetic information, nutritional advice, and thousands of new scientific publications appear every year. Yet many people still struggle to answer a simple question:
What does all of this mean for me?
Ayesha BioMed was created to bridge this gap.
Our philosophy is based on three principles:
-
Interpret before intervening.
-
Understand biology before treating numbers.
-
Support long-term physiological resilience rather than short-term symptom suppression.
We believe that meaningful health decisions require thoughtful interpretation, scientific context, and an appreciation of how biological systems interact—not simply more tests or more treatments.
What Makes Ayesha BioMed Different?
The scientific foundation of Ayesha BioMed combines expertise developed across three complementary environments:
Academic Research
Fundamental research in molecular immunology, endogenous peptide biology, and systems biology at internationally recognised research institutions.
Translational Biotechnology
More than two decades of translating biological discoveries into therapeutic innovation, including peptide drug discovery, intellectual property development, and biotechnology leadership.
Independent Biomedical Research
Current research integrating computational biology, host–pathogen interactions, endogenous peptide signalling, and systems-level physiology to develop new concepts in preventive medicine and precision therapeutics.
This unique combination allows scientific discoveries to be translated into practical guidance for everyday health.
Our Approach
Rather than asking,
"Which supplement should I take?"
we ask,
"What biological process is driving this pattern?"
Our guidance integrates:
-
laboratory interpretation
-
physiology
-
metabolism
-
inflammation
-
endocrine regulation
-
nutrition
-
lifestyle
-
systems biology
-
current biomedical evidence
The objective is to identify meaningful biological priorities rather than isolated abnormalities.
Why Guidance Rather Than Treatment?
Ayesha BioMed does not diagnose disease, prescribe medication, or replace medical care.
Instead, we provide scientific interpretation and preventive biomedical guidance that complements conventional healthcare.
Our work focuses on:
-
interpretation of health and laboratory data
-
understanding biological patterns
-
evidence-informed lifestyle strategies
-
nutritional guidance
-
supplement evaluation
-
longitudinal monitoring
-
preventive health
This clear boundary preserves scientific integrity while respecting the essential role of licensed healthcare professionals.
The Meaning Behind the Name
The foundation of the name comes from an inspiring legacy, dedicated to my late wife Ayesha's enduring passion for compassionate care, together with years of scientific training in molecular biology, translational biomedical research, systems biology, and biological signalling.
Ayesha BioMed reflects the belief that health guidance should combine scientific excellence with compassion, humility, and respect for every individual's unique journey.
Meet Dr. Nisar Khan, PhD (Cum Laude)
Translational Biomedical Scientist | Systems Biologist | Immunologist | Peptide Drug Innovator
For more than twenty-five years, I have worked at the interface of academic science, biotechnology and translational medicine, with one central scientific question guiding my research:
How do endogenous biological signalling systems regulate human physiology, and how can understanding these mechanisms be translated into innovative therapeutics and preventive health?
I obtained my MSc in Medical Biology from the University of Amsterdam, including a research internship at the University of Maryland School of Medicine, followed by a PhD (cum laude) in Biomedical Sciences at Erasmus University Rotterdam. During my academic career, I combined research in molecular immunology with teaching and supervision of undergraduate, Master's and medical students.
About Me
From Biology to Biomedical Innovation
My early research focused on one of biology's most remarkable physiological phenomena: maternal immune tolerance during pregnancy.
This work led to the discovery that short peptide fragments derived from naturally occurring human proteins possess distinct immunoregulatory and anti-inflammatory properties. These findings contributed to expanding our understanding of endogenous peptide signalling and resulted in an extensive international intellectual property portfolio covering inflammatory diseases, tissue protection, metabolic disorders, infectious diseases and regenerative medicine.
Over the following years, I translated these biological discoveries into therapeutic innovation, contributing to the development of novel peptide-based approaches for immune regulation and disease modification. This work combined fundamental biological research with translational science, bridging laboratory discoveries and practical biomedical applications.
Systems Biology and Scientific Innovation
More recently, my work has expanded towards systems biology and computational approaches to understanding physiological regulation.
Rather than studying individual molecules in isolation, I investigate how biological information is organised across interconnected signalling networks and how these interactions influence health, disease, adaptation and ageing.
This interdisciplinary research combines molecular biology, immunology, computational analysis and translational medicine to identify new opportunities for biomedical innovation while improving our understanding of complex biological systems.
A Broader Biological Perspective
Beyond individual discoveries, my research has contributed to a broader biological perspective.
Traditionally, proteins have been viewed primarily as the functional end products of gene expression.
My work proposes that proteins may also serve as reservoirs of biologically active regulatory peptide information, providing an additional layer through which cells and tissues communicate and regulate physiological processes.
This systems-level perspective connects molecular biology with physiology and offers new ways of thinking about biological communication, adaptation and therapeutic intervention. It continues to guide my research in immunology, peptide science, systems biology and preventive medicine.
Translating Science into Prevention
Today, Ayesha BioMed represents the continuation of this scientific journey.
The same systems-level thinking that has guided my work in molecular biology, immunology, translational research and biomedical innovation is now applied to personalised preventive health guidance.
Rather than focusing solely on disease after it develops, my goal is to help individuals better understand the biological processes underlying their health through thoughtful interpretation of laboratory data, lifestyle, physiology and current scientific evidence.
Ayesha BioMed brings together decades of biomedical research with a commitment to translating complex science into practical, ethical and evidence-informed guidance that supports healthier ageing, disease prevention and informed decision-making.
Looking Ahead
I believe the future of biology and medicine lies in understanding health as an integrated system rather than a collection of isolated pathways.
My long-term vision is to continue advancing the integration of molecular biology, endogenous signalling, systems biology and translational science into approaches that improve both therapeutic innovation and preventive healthcare.